PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15044558-0	2004	UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.	Oxazepam	116-124	UDP glucuronosyltransferase family 2 member B15	Homo sapiens	0-38	
15044558-0	2004	UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.	Oxazepam	116-124	UDP glucuronosyltransferase family 2 member B15	Homo sapiens	57-64	
15044558-3	2004	We have previously shown that S-oxazepam glucuronide, the major oxazepam metabolite, is selectively formed by UDP-glucuronosyltransferase (UGT) 2B15, whereas the minor R-oxazepam glucuronide is produced by multiple UGTs other than UGT2B15.	Oxazepam	32-40	UDP glucuronosyltransferase family 2 member B15	Homo sapiens	110-148	
15044558-3	2004	We have previously shown that S-oxazepam glucuronide, the major oxazepam metabolite, is selectively formed by UDP-glucuronosyltransferase (UGT) 2B15, whereas the minor R-oxazepam glucuronide is produced by multiple UGTs other than UGT2B15.	Oxazepam	32-40	UDP glucuronosyltransferase family 2 member B15	Homo sapiens	231-238